# A Study of HQP1351 in Patients With GIST or Other Solid Tumors

> **NCT03594422** · PHASE1 · RECRUITING · sponsor: **Ascentage Pharma Group Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Gastrointestinal Stromal Tumor (GIST)
- Solid Tumor, Adult

## Interventions

- **DRUG:** HQP1351

## Key facts

- **NCT ID:** NCT03594422
- **Lead sponsor:** Ascentage Pharma Group Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-11
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594422, "A Study of HQP1351 in Patients With GIST or Other Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03594422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*